SEC-PR-2412-201 (Dec. 16, 2024) (SEC-PR-2412) Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump – New Jersey-based company will also retain independent compliance consultant Excerpt: Washington D.C., Dec. 16, 2024 — The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer […]
Category: Misleading Investors
SEC-PR-2412-189 (Dec. 3, 2024) (SEC-PR-2412) SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews – SEC declines to impose civil penalties against company due to its self-reporting, remediation, and cooperation. Excerpt: Washington D.C., Dec. 3, 2024 — The Securities and Exchange Commission today filed settled charges against […]